Takeda Pharmaceutical Other Non-Current Liabilities 2010-2024 | TAK

Takeda Pharmaceutical other non-current liabilities for the quarter ending September 30, 2024 were $4.588B, a 0.63% decline year-over-year.

  • Takeda Pharmaceutical other non-current liabilities for 2024 were $5.434B, a 7.96% increase from 2023.
  • Takeda Pharmaceutical other non-current liabilities for 2023 were $5.033B, a 7.29% decline from 2022.
  • Takeda Pharmaceutical other non-current liabilities for 2022 were $5.429B, a 10.74% decline from 2021.

Takeda Pharmaceutical Other Non-Current Liabilities 2010-2024 | TAK

  • Takeda Pharmaceutical other non-current liabilities for 2024 were $5.434B, a 7.96% increase from 2023.
  • Takeda Pharmaceutical other non-current liabilities for 2023 were $5.033B, a 7.29% decline from 2022.
  • Takeda Pharmaceutical other non-current liabilities for 2022 were $5.429B, a 10.74% decline from 2021.